With 200 m² of laboratory space divided into several specialised platforms within the Neurocentre Magendie, PUMA brings together all the technologies for the extraction and characterisation of biomolecules and is now labelled by the Federation of Platforms of the University of Bordeaux.
PUMA integrates all five pre-existing platforms at Magendie (Genotyping, Laser-assisted Microdissection, Transcriptome, Analytical Chemistry, as well as the Bioinformatics service, which all have more than 10 years of expertise. PUMA is a coherent shared facility for the academic and private scientific communities, mainly in the life and health sciences.
PUMA is composed of researchers and engineers who share their expertise for the characterisation and quantification of biomolecules, such as RNA, DNA, proteins, and lipids. This know-how represents a continuum of expertise ranging from tissue or cell genotyping analysis after laser microdissection, to steroid and cannabinoid analysis by mass spectrometry. Because of the know-how of the technical manager for PUMA services, we can offer to process samples of very diverse origins, in vitro cell lines, humans, animals (monkeys, rodents, dogs, insects, etc.), plants through clinical research projects. PUMA has developed automated and standardised high-throughput methods that ensure rapid and reliable analysis. PUMA activities are carried out through dedicated equipment and personnel, which guarantees repeatability, traceability, and confidentiality of data.
The uniqueness of PUMA is also to offer the users an assistance and guidance throughout the project, from the design stage to the choice of methods and analysis of the results.
Today, more than 45 academic research units (INSERM, CNRS, INRA) and more than 20 private companies in France and internationally are already using PUMA, highlighting a wide national and international opening.
The PUMA platforms are under the responsibility of each of the technical managers running the platforms and coordinated by S. Oliet (Director of the Neurocentre Magendie) and the General Secretary, with the support of a dedicated scientific committee composed of 3 team leaders (D. Cota, J.M. Revest and E. Pacary).
